Return On Assets of Theravance Biopharma, Inc. from 30 Sep 2014 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Theravance Biopharma, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2014 to 30 Sep 2025.
  • Theravance Biopharma, Inc. Return On Assets for the quarter ending 30 Sep 2025 was 7.6%.
  • Theravance Biopharma, Inc. annual Return On Assets for 2024 was -16%, a 26% decline from 2023.
  • Theravance Biopharma, Inc. annual Return On Assets for 2023 was -12%, a 107% decline from 2022.
  • Theravance Biopharma, Inc. annual Return On Assets for 2022 was 167%.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Theravance Biopharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 7.6% +21% 01 Jul 2025 30 Sep 2025
Q2 2025 3.5% +15% 01 Apr 2025 30 Jun 2025
Q1 2025 -16% -5.4% -48% 01 Jan 2025 31 Mar 2025
Q4 2024 -16% -3.2% -26% 01 Oct 2024 31 Dec 2024
Q3 2024 -13% -2.1% -18% 01 Jul 2024 30 Sep 2024
Q2 2024 -12% -159% -108% 01 Apr 2024 30 Jun 2024
Q1 2024 -11% -165% -107% 01 Jan 2024 31 Mar 2024
Q4 2023 -12% -180% -107% 01 Oct 2023 31 Dec 2023
Q3 2023 -11% -195% -106% 01 Jul 2023 30 Sep 2023
Q2 2023 147% +175% 01 Apr 2023 30 Jun 2023
Q1 2023 154% +192% 01 Jan 2023 31 Mar 2023
Q4 2022 167% +218% 01 Oct 2022 31 Dec 2022
Q3 2022 183% +237% 01 Jul 2022 30 Sep 2022
Q2 2022 -27% +32% +54% 01 Apr 2022 30 Jun 2022
Q1 2022 -37% +20% +35% 01 Jan 2022 31 Mar 2022
Q4 2021 -50% +1.3% +2.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -54% +0.68% +1.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -59% -5.8% -11% 01 Apr 2021 30 Jun 2021
Q1 2021 -57% -6.6% -13% 01 Jan 2021 31 Mar 2021
Q4 2020 -52% -1.3% -2.6% 01 Oct 2020 31 Dec 2020
Q3 2020 -55% -11% -25% 01 Jul 2020 30 Sep 2020
Q2 2020 -53% -7.9% -17% 01 Apr 2020 30 Jun 2020
Q1 2020 -51% -3.2% -6.9% 01 Jan 2020 31 Mar 2020
Q4 2019 -50% -3.3% -7.1% 01 Oct 2019 31 Dec 2019
Q3 2019 -44% +15% +26% 01 Jul 2019 30 Sep 2019
Q2 2019 -45% +11% +20% 01 Apr 2019 30 Jun 2019
Q1 2019 -47% +11% +19% 01 Jan 2019 31 Mar 2019
Q4 2018 -47% +8.4% +15% 01 Oct 2018 31 Dec 2018
Q3 2018 -59% -12% -25% 01 Jul 2018 30 Sep 2018
Q2 2018 -57% -13% -30% 01 Apr 2018 30 Jun 2018
Q1 2018 -58% -15% -34% 01 Jan 2018 31 Mar 2018
Q4 2017 -55% -9.6% -21% 01 Oct 2017 31 Dec 2017
Q3 2017 -47% +3.7% +7.3% 01 Jul 2017 30 Sep 2017
Q2 2017 -44% +15% +26% 01 Apr 2017 30 Jun 2017
Q1 2017 -44% +20% +32% 01 Jan 2017 31 Mar 2017
Q4 2016 -46% +16% +26% 01 Oct 2016 31 Dec 2016
Q3 2016 -51% +16% +24% 01 Jul 2016 30 Sep 2016
Q2 2016 -59% +3.4% +5.4% 01 Apr 2016 30 Jun 2016
Q1 2016 -64% -4.3% -7.2% 01 Jan 2016 31 Mar 2016
Q4 2015 -62% +18% +23% 01 Oct 2015 31 Dec 2015
Q3 2015 -67% +34% +34% 01 Jul 2015 30 Sep 2015
Q2 2015 -63% 01 Apr 2015 30 Jun 2015
Q1 2015 -60% 01 Jan 2015 31 Mar 2015
Q4 2014 -81% 01 Oct 2014 31 Dec 2014
Q3 2014 -100% 01 Jul 2014 30 Sep 2014

Theravance Biopharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -16% -3.2% -26% 01 Jan 2024 31 Dec 2024
2023 -12% -180% -107% 01 Jan 2023 31 Dec 2023
2022 167% +218% 01 Jan 2022 31 Dec 2022
2021 -50% +1.3% +2.5% 01 Jan 2021 31 Dec 2021
2020 -52% -1.3% -2.6% 01 Jan 2020 31 Dec 2020
2019 -50% -3.3% -7.1% 01 Jan 2019 31 Dec 2019
2018 -47% +8.4% +15% 01 Jan 2018 31 Dec 2018
2017 -55% -9.6% -21% 01 Jan 2017 31 Dec 2017
2016 -46% +16% +26% 01 Jan 2016 31 Dec 2016
2015 -62% +18% +23% 01 Jan 2015 31 Dec 2015
2014 -81% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.